Seeing Is Believing
Currently out of the existing stock ratings of Travis Steed, 46 are a HOLD (29.87%), 96 are a BUY (62.34%), 12 are a SELL (7.79%).
Analyst Travis Steed, currently employed at BAML, carries an average stock price target met ratio of 59.2% that have a potential upside of 19.42% achieved within 239 days.
Travis Steed’s has documented 307 price targets and ratings displayed on 31 stocks. The coverage is on Healthcare, Financial Services, Communication Services sectors.
Most recent stock forecast was given on BDX, Becton Dickinson and Company at 31-Aug-2026.
Analyst best performing recommendations are on LUNG (PULMONX CORP).
The best stock recommendation documented was for LUNG (PULMONX CORP) at 1/3/2023. The price target of $8 was fulfilled within 1 day with a profit of $0.51 (6.81%) receiving and performance score of 68.09.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 17-Dec-2018
$120
$20.4 (20.48%)
$143
Buy Since 23-Jan-2017
$135
$35.4 (35.54%)
$135
1 months 3 days ago
(08-Sep-2026)
26/39 (66.67%)
$29.48 (27.94%)
336
Hold Since 13-Aug-2026
$130
$30.4 (30.52%)
1 months 28 days ago
(13-Aug-2026)
2/3 (66.67%)
$18.73 (16.83%)
29
Buy Since 28-Jul-2026
$125
$25.4 (25.50%)
$117
2 months 13 days ago
(28-Jul-2026)
4/5 (80%)
$17.73 (16.53%)
116
Buy Since 06-Jun-2019
$112
$12.4 (12.45%)
$108
2 months 24 days ago
(17-Jul-2026)
25/32 (78.13%)
$11.32 (11.24%)
420
Which stock is Travis Steed most bullish on?
Which stock is Travis Steed most reserved on?
What Year was the first public recommendation made by Travis Steed?